About Redpin therapeutics

About company

Redpin Therapeutics operates as a preclinical stage gene therapy company. It develops a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Its approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. The company was founded in 2017 and is headquartered in New York.